European Union

AstraZeneca’s Imfinzi Recommended for EU Approval as Breakthrough Treatment for Limited-Stage Small Cell Lung Cancer

(IN BRIEF) AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for…

9 months ago

EIB Report Highlights Innovation Progress and Challenges in CESEE Region

(IN BRIEF) The European Investment Bank (EIB) presented a report at the Invisso Conference in Vienna examining innovation progress in…

9 months ago